Cardiovascular disease in patients requiring NIV for ECOPD.
N. Lane (Newcastle upon Tyne, United Kingdom), T. Hartley (Newcastle upon Tyne, United Kingdom), J. Steer (Newcastle upon Tyne, United Kingdom), M. Elliott (Leeds, United Kingdom), M. Sovani (Nottingham, United Kingdom), H. Curtis (Gateshead, United Kingdom), E. Fuller (South Tyneside, United Kingdom), P. Murphy (London, United Kingdom), D. Shrikrishna (Taunton, United Kingdom), K. Lewis (Wales, United Kingdom), N. Ward (Plymouth, United Kingdom), C. Turnbull (Oxford, United Kingdom), V. Ferguson (Newcastle upon Tyne, United Kingdom), N. Hart (London, United Kingdom), S. Bourke (Newcastle upon Tyne, United Kingdom)
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Session: Cardiovascular comorbidities in COPD
Session type: Thematic Poster
Number: 2655
Disease area: -
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Lane (Newcastle upon Tyne, United Kingdom), T. Hartley (Newcastle upon Tyne, United Kingdom), J. Steer (Newcastle upon Tyne, United Kingdom), M. Elliott (Leeds, United Kingdom), M. Sovani (Nottingham, United Kingdom), H. Curtis (Gateshead, United Kingdom), E. Fuller (South Tyneside, United Kingdom), P. Murphy (London, United Kingdom), D. Shrikrishna (Taunton, United Kingdom), K. Lewis (Wales, United Kingdom), N. Ward (Plymouth, United Kingdom), C. Turnbull (Oxford, United Kingdom), V. Ferguson (Newcastle upon Tyne, United Kingdom), N. Hart (London, United Kingdom), S. Bourke (Newcastle upon Tyne, United Kingdom). Cardiovascular disease in patients requiring NIV for ECOPD.. 2655
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: